FY2026 Earnings Estimate for EHC Issued By Leerink Partnrs

Encompass Health Co. (NYSE:EHC) – Investment analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for shares of Encompass Health in a report issued on Wednesday, October 30th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $5.00 per share for the year, up from their previous forecast of $4.71. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.28 per share.

Several other research analysts also recently commented on the company. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Barclays upped their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Stephens restated an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Finally, UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Up 1.3 %

Shares of Encompass Health stock opened at $100.23 on Monday. Encompass Health has a 1-year low of $62.58 and a 1-year high of $102.36. The company’s fifty day simple moving average is $94.66 and its 200-day simple moving average is $89.09. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.35. The stock has a market capitalization of $10.09 billion, a PE ratio of 24.21, a P/E/G ratio of 1.32 and a beta of 0.88.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.86 EPS.

Encompass Health announced that its board has authorized a stock repurchase plan on Wednesday, July 24th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to repurchase up to 5.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. Encompass Health’s dividend payout ratio is presently 16.43%.

Insiders Place Their Bets

In related news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares in the company, valued at approximately $11,761,839.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in EHC. UMB Bank n.a. raised its stake in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC increased its holdings in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares during the period. Oakworth Capital Inc. bought a new stake in Encompass Health during the 2nd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after buying an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Encompass Health during the 2nd quarter worth $58,000. Institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.